Awakn Life Sciences: Key Patent Filed Covering Behavioral Addictions With Ketamine And Ketamine-Assisted Therapy May 27, 2022
Awakn Life Sciences Files Patent Cooperation Treaty (PCT) Application For The Treatment Of Behavioral Addictions May 26, 2022
atai Life Sciences: Unparalleled Diversification With 10 Psychedelic Compounds Going Into Clinical Trials In 2022 May 25, 2022
Creso Pharma Secures Agreement With Australia’s Leading Tattoo Aftercare Products Company May 24, 2022
